“Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus”, Khwaja Yunus Ali Medical College Journal, vol. 16, no. 3, pp. 119–122, Jun. 2026, doi: 10.3329/kyamcj.v16i3.88022.